Financial Performance - Revenue increased by 1.3% year-over-year to $6,049 million[12] - Adjusted EBITDA increased by 1.5% year-over-year to $2,762 million[12] - Adjusted EPS increased by 5.3% to $0.79[12] - Free cash flow increased by 20.6% to $1,003 million[14] - Capital expenditures decreased by 6.6% year-over-year to $891 million[12] Subscriber Metrics - Postpaid churn rate improved by 15 bps year-over-year[6] - Retail FTTH Internet net additions were 65,239[9] - Crave subscribers increased by 24% year-over-year to 4.3 million[9] Bell Media - Bell Media revenue decreased by 6.4% year-over-year to $732 million[23] - Bell Media adjusted EBITDA decreased by 6.7% year-over-year to $237 million[24] Bell CTS U.S.(Ziply Fiber) - Bell CTS U.S revenue was $160 million for the 2-month period from August 1, 2025 through September 30, 2025[18] - Bell CTS U.S adjusted EBITDA was $71 million for the 2-month period from August 1, 2025 through September 30, 2025[18]

Financial Performance - FY25 revenue reached $21.84 billion, with adjusted FXN growth of 7.7% and organic growth of 2.9%[16,44] - Adjusted diluted EPS for FY25 was $14.40, a 9.6% year-over-year increase[16] - Adjusted operating margin for FY25 was 25.0%, an increase of 80 bps year-over-year[16] - The company returned $2.2 billion to shareholders through share repurchases and dividends[16,48] - Free cash flow for FY25 was $2.67 billion, a 14% decrease compared to FY24's $3.119 billion[47] Segment Performance (Q4 FY25) - BD Medical segment revenue was $3.155 billion, with a 9.9% FXN increase[34] - BD Life Sciences segment revenue was $1.368 billion, with a 0.3% FXN increase[36] - BD Interventional segment revenue was $1.367 billion, with a 7.5% FXN increase[39] FY26 Guidance - The company expects low single-digit revenue growth (FXN) for FY26, including a ~90 bps FX tailwind[53] - Adjusted diluted EPS for FY26 is projected to be between $14.75 and $15.05, a 2.4% to 4.5% increase[53]

Financial Performance - Total revenues for Q3 2025 increased by 30% to US$97.3 million[13, 43] - RUCONEST® revenues in Q3 2025 reached US$82.2 million[13, 22] - Joenja® revenues in Q3 2025 amounted to US$15.1 million[13, 27] - Operating profit significantly grew to US$16.0 million in Q3 2025[13, 43] - Cash flow from operations was US$32 million in Q3 2025[14, 41] - Total revenues for 9M 2025 grew 33% to US$269.6 million[44, 45] Business Updates and Outlook - 2025 revenue guidance raised to US$365-375 million due to strong RUCONEST® performance[14, 51] - RUCONEST® U S volume growth was +24% in 3Q25 and +28% in 9M25[22] - There are 116 US patients on Joenja® representing a +25% increase vs 3Q24[27] - FDA filing for Leniolisib for 4-11 year old APDS patients is based on Phase III data and has a PDUFA date of Jan 31, 2026[28]

Financial Performance - Q3 2025 - Net sales increased by 30% to $1227 billion compared to the prior year[8] - Net income decreased by 392% to $395 million[8, 15] - Adjusted EBITDA decreased by 114% to $1181 million[8] - GAAP diluted EPS decreased by $012 to $019[8] - Adjusted diluted EPS decreased by $010 to $023[8] Sales Highlights - Q3 2025 - Branded Retail net sales increased by 69% due to the acquisition contribution, partly offset by volume declines and unfavorable price/mix[11] - Other net sales decreased by 38% due to unfavorable price/mix, partially offset by increased volume for non-retail items[11] Fiscal Year 2025 Guidance - Net Sales are projected to be between $5254 billion and $5306 billion[20] - Adjusted EBITDA is expected to be between $515 million and $532 million[20] - Adjusted diluted EPS is forecasted to be between $102 and $108[20] Market Share and Volume Trends - Flowers Fresh Packaged Breads dollar sales decreased by 29% and unit sales decreased by 18%[40] - Flowers Commercial Cake dollar sales increased by 10% and unit sales increased by 11%[43]

What we are presenting today OUR VISION AND COMMITMENTS OUR PLATFORMS OUR FINANCIALS Rui Teixeira Miguel Stilwell d'Andrade (CEO) 2 2 3 Miguel Stilwell d'Andrade (CEO) (CFO) CLOSING REMARKS 4 5 Power demand at an inflection point – an era of sustained growth driven by tech and electrification 2024 2025 2030 2035 ~6.6 ~6.7 ~7.8 ~8.9 ~20% ~25% Electrification share of final energy consumption Millions of EVs1 on the roads GW of DC capacity installed Electricity demand2 000' TWh +2-3% CAGR 1. Includes BEV, PHE ...

Financial Performance - Fiscal Year 26 Q1 organic net sales growth was flat, but reported sales were negatively impacted by disposals[9, 10] - The flat organic net sales growth reflects an approximate 2.5% impact from Chinese white spirits[8, 21] - Adverse price/mix offset positive volume, largely driven by market conditions[8, 21] Regional Performance - Europe experienced strong growth at +3.5%, while Latin America and Caribbean grew +10.9%, and Africa +8.9%[12] - North America saw a decline of -2.7% due to a weaker US consumer environment and tequila category weakness[12] - Asia Pacific experienced a decline of -7.5%, impacted by weakness in Chinese white spirits[12] Future Outlook - Fiscal Year 26 free cash flow guidance is reiterated at approximately $3 billion, underpinned by managing maturing stock, A&P effectiveness, capex, and costs[8, 21] - Fiscal Year 26 organic net sales growth is expected to be flat to slightly down, including the impact from Chinese white spirits and a weaker US consumer environment[18] - Fiscal Year 26 organic operating profit growth is expected to be low to mid-single digit, updated for the revised organic net sales growth, including Accelerate and tariffs impact[18] Strategic Initiatives - The Accelerate programme is progressing well, simplifying the operating model for clearer, faster decision-making[8, 21] - The company aims for approximately $625 million in cost savings over 3 years through the Accelerate programme[15]

Financial Performance - Underlying operating profit increased by 13% to £2,292 million, compared to £2,026 million in HY25[33] - Underlying EPS increased by 6% to 29.8 pence, compared to 28.0 pence in HY25[33] - Capital investment increased by 12% to £5,052 million, compared to £4,494 million in HY25[33] - Dividend increased by 3.2% to 16.35 pence, compared to 15.84 pence in HY25[33] - Finance costs increased to £678 million, compared to £652 million in HY25[106] - Underlying earnings increased by 16% to £1,470 million, compared to £1,269 million in HY25[106] Strategic Investment and Growth - The company plans for approximately £60 billion in capital investment, with around £51 billion allocated to green initiatives[14] - The company aims for a group asset compound annual growth rate (CAGR) of approximately 10% from FY24 baseline[14] - Over 75% of the £60 billion investment plan is underpinned by delivery mechanisms[18] Business Segments - UK Electricity Distribution underlying operating profit was £551 million[79] and capital investment was £756 million[40] - UK Electricity Transmission underlying operating profit was £846 million[82] and capital investment was £1,684 million[45] - US New York underlying operating profit was £443 million[90] and capital investment was £1,585 million[55] - US New England underlying operating profit was £292 million[95] and capital investment was £958 million[64]

Financial Performance - The company reported underlying revenue growth of 50% in Q3 2025, consistent with H1[8] - Total revenue for Q3 2025 reached $1501 million[13] - The company is raising free cash flow guidance from over $600 million to around $750 million[10, 33] - The company maintains its 2025 trading margin guidance of 190-200%[33] Business Segment Performance - Orthopaedics revenue reached $577 million, with underlying growth of 41%[14, 17] - Sports Medicine & ENT revenue was $469 million, reflecting underlying growth of 51%[14, 21] - Advanced Wound Management (AWM) achieved revenue of $455 million, with underlying growth of 60%[14, 27] Regional Performance - The US market grew by 55% with revenue of $789 million[14] - Emerging Markets grew by 54% with revenue of $265 million[14] - Other Established Markets increased by 39% with revenue of $447 million[14] Key Growth Drivers and Outlook - The company expects ongoing improvement in US Recon through the 12-Point Plan, along with continued strong performance in Sports & ENT (excluding China) and AWM[34] - The company anticipates approximately 150 bps growth headwind from China[34] - Innovation, including products like REGENETEN, CARTIHEAL, and ALLEVYN CC, is expected to drive future growth[35, 39]

Strategy and Electrification - Volvo Cars aims to resolve three key challenges: unique opportunities, end of globalization, and hyper competition[9, 10] - Electrification is the future, with a focus on better cars and accelerating the transition[11, 13] - The company is targeting up to a 20% reduction in marketing spend per car through a new approach to marketing[45] - Volvo Cars is transitioning to electric faster than other premium legacy OEMs, showing significant growth in electrified share of volume[54, 55] - The company is building a longer bridge to electrification with compelling long-range hybrid products[51, 63] Synergies and Cost Efficiency - Increased collaboration with Geely will be key to further reduce costs and get products to market quicker[51, 73] - Volvo Cars aims for up to 8% savings from joint negotiations with common suppliers[98] - The company is executing on a near-term SEK 18 billion cost and cash action plan[160] - Geely ranks 3 globally in BEV market share, providing unique access to China's cost structure and ecosystem[178] - Volvo Cars is targeting a structural long-term profitability of >8% EBIT[169, 184]

Worldline's Current Status and Strategy - Worldline is a leading pan-European acquirer and operator of critical infrastructure for merchants and financial institutions[36] - The company's 2025 pro forma total revenues are approximately €4.0 billion[38], with adjusted EBITDA between €720 million and €745 million[39] - Merchant Services account for approximately 80% of revenue, while Financial Institutions contribute approximately 20%[42] - Worldline aims to be the European payments partner of choice for merchants and financial institutions[69] North Star 2030 Transformation Plan - The North Star 2030 plan is expected to deliver €210 million of additional recurring adjusted EBITDA[74] - The plan focuses on four key drivers: simplifying the operating model, converging platforms, integrating operations through GCCs, and growing through efficiency and revenue management[73] - By 2030, the company targets over €1 billion in adjusted EBITDA and €300 million to €350 million in free cash flow[84] - Platform convergence is projected to contribute 40% to the North Star 2030 adjusted EBITDA[116] - Integrating operations through GCCs is expected to contribute 20% to the North Star 2030 adjusted EBITDA[153] Financial Targets and Capital Allocation - Worldline confirms its 2025 guidance with an illustrative pro-forma revenue of approximately €4.0 billion and adjusted EBITDA between €720 million and €745 million[306] - The company anticipates €350 million to €400 million in cash proceeds from divestments in 2026[65] - A contemplated capital raise of €500 million is planned, anchored by strategic investors, expected in Q1 2026[340, 341] - By 2030, Worldline targets revenue growth with approximately 4% CAGR from 2027-2030 and free cash flow between €300 million and €350 million[314, 352]